Nutritional Genomics: Implications for Age-Related Macular Degeneration. [PDF]
Figueiredo I+8 more
europepmc +1 more source
Efficacy and safety of brolucizumab every 6 weeks induction therapy for neovascular age-related macular degeneration. [PDF]
Honda S+6 more
europepmc +1 more source
Risk factors for age-related macular degeneration: Updated systematic review and meta-analysis. [PDF]
Babaker R+7 more
europepmc +1 more source
Modifiable Lifestyle Risk Factors and Strategies for Slowing the Progression of Age-Related Macular Degeneration. [PDF]
Saigal K+4 more
europepmc +1 more source
Dry and neovascular "wet" age-related macular degeneration: Upcoming therapies. [PDF]
Yan A, Hasan N, Chhablani J.
europepmc +1 more source
Impact of residual retinal fluid on treatment outcomes in neovascular age-related macular degeneration. [PDF]
Zur D+8 more
europepmc +1 more source
A cross-sectional observational study of the association between biochemistry profiles and the risk of age-related macular degeneration. [PDF]
Bai S, Zhang L, Yan W, Wang H.
europepmc +1 more source
Intravitreal Faricimab for Previously Treated Neovascular Age-Related Macular Degeneration. [PDF]
Hang A+6 more
europepmc +1 more source
Clinical Outcomes of an Enhanced and Conventional Monofocal IOL in Patients with Early and Intermediate Dry Age-Related Macular Degeneration. [PDF]
Venter JA+8 more
europepmc +1 more source